Иммунный ответ при вакцинации против гепатита В

03.02.2011

Литература

  1. Зубкин М.Л. HBV- и HCV-инфекции у больных, получающих лечение программным гемодиализом; алгоритм вакцинопрофилактики гепатита В при хронической почечной недостаточности: Автореф. дис. … докт. мед. наук. – М., 2004.
  2. Никитина Т.Н., Авдеева Ж.И. Иммуноадъювантное действие цитокинов при иммунизации животных вакциной против гепатита В // Цитокины и воспаление. 2009. № 8 (1). C. 28 – 31.
  3. Новая нановакцина против гепатита В дает сильный иммунитет. Опубликовано в NanoWeek, 25 – 31 августа 2008, № 32.
  4. Онищенко Г.Г. Актуальные проблемы профилактики инфекционных болезней на современном этапе // ЖМЭИ. 2010. № 4. С. 13 – 22.
  5. О санитарно-эпидемиологической ситуации в Российской Федерации в 2008 году: Государственный доклад. – М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора, 2009. – 467 с.
  6. Семененко Т.А. Гуморальный и клеточный иммунный ответ при иммунизации вакцинами против гепатита А // Эпидемиология и Вакцинопрофилактика. 2006. № 5 (30). С. 56 – 59.
  7. Семененко Т.А. Вакцина Твинрикс для профилактики гепатита А и В // Эпидемиология и Вакцинопрофилактика. 2007. № 2 (33). С. 53 – 55.
  8. Семененко Т.А. Хронический гепатит В и проблема персистенции вируса с позиций иммунопатогенеза заболевания // ЖМЭИ. 2009. № 4. С. 33 – 39.
  9. Хаитов Р.М., Пинегин Б.В. Иммуномодуляторы: механизм действия и клиническое применение // Иммунология. 2003. № 4. С. 196 – 203.
  10. Abzug M.J., Warshaw M., Rosenblatt H.M. et al. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIVinfected children receiving highly active antiretroviral therapy // J. Infect. Dis. 2009. V. 200 (6). P. 935 – 946.
  11. Banatvala J.E., Van Damme P. Hepatitis B vaccine . do we need boosters? // J. Viral. Hepat. 2003. V. 10 (1). P. 1 . 6.
  12. Bauer T., Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination // Vaccine. 2006. V. 24 (5). P. 572 . 577.
  13. Bauer T., Gunther M., Bienzle U. et al. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells // Liver Transpl. 2007. V. 13 (3). P. 434 . 442.
  14. Bocher W.O., Herzog-Hauff S., Schlaak J. et al. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma // Hepatology. 1999. V. 29 (1). P. 238 . 244.
  15. Buxton J.A., Kim J.H. Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: A review of the evidence and current recommendations // Can. J. Infect. Dis. Med. Microbiol. 2008. V 19 (2). "Q. 197 . 202.
  16. Cardell K., Akerlind B., Sallberg M., Fryden A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine // J. Infect. Dis. 2008. V. 198 (3). P. 299 . 304.
  17. Centers for Disease Control and Prevention. Recommendations and Reports: Hepatitis A and B vaccines // MMWR. 2003. V. 52 (RR01). P. 34 . 36.
  18. Cooper C.L., Davis H.L., Morris M.L. et al. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study // J. Clin. Immunol. 2004. V. 24. P. 693 . 701.
  19. Godkin A., Davenport M., Hill A.V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness // Hepatology. 2005. V. 41 (6). P. 1383 . 1390.
  20. Hohler T., Stradmann-Bellinghausen B., Starke R. et al. C4A deficiency and nonresponse to hepatitis B vaccination // J. Hepatol. 2002. V. 37. P. 387 . 392.
  21. Hohler T., Groeger-Bicanic G., Hoet B., Stoffel M. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults // Vaccine. 2007. V. 25 (8). "Q. 1503 . 1508.
  22. Hollinger F.B. Comprehensive control (or elimination) of hepatitis "B virus transmission in the United States // Gut. 1996; 38 (Suppl. 2): S24 . 30.
  23. Jilg W. Hepatitis B vaccination in the immunosuppressed // Dtsch. Med. Wochenschr. 1993. V. 118 (20). P. 762 . 764.
  24. Joines R.W., Blatter M., Abraham B. et al. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults // Vaccine. 2001. V. 19 (32). P. 4710 . 4719.
  25. Kardar G.A., Jeddi-Tehrani M., Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine // Scand. J. Immunol. 2002. V. 55. P. 311 . 314.
  26. Keeffe E.B. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination // Am. J. Med. 2005. V. 118 (10A). P. 21S . 27S.
  27. Keeffe E.B. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases // Trans. Am. Clin. Climatol. Assoc. 2006. V. 117. P. 227 . 238.
  28. Kramer E.S., Hofmann C., Smith P.G. et al. Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis // Dig. Dis. Sci. 2009. V. 54 (9). P. 16 . 25.
  29. Lavanchy D. Global HCV prevention and control measures: lessons learnt and opportunities // Viral Hepatitis. 2010. V. 18 (2). P. 23 . 24.
  30. Lau D.T., Hewlett A.T. Screening for hepatitis A and B antibodies in patients with chronic liver disease // Am. J. Med. 2005. V. 118 (10A). P. 28S . 33S.
  31. Li Y., Ni R., Song W. et al. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth // Hum. Genet. 2009. V. 126 (5). P. 685 . 696.
  32. Litjens N.H., Huisman M., van den Dorpel M. et al. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients // J. Am. Soc. Nephrol. 2008. V. 19 (8). P. 1483 . 1490.
  33. McNulty C.A., Bowen J.K., Williams A.J. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules // Vaccine. 2005. V. 23 (32). P. 4142 . 4147.
  34. Miquilena-Colina M.E., Lozano-Rodriguez T., Garcia-Pozo L. et al. Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial // Vaccine. 2009. V. 27 (41). P. 5654 . 5660.
  35. Mizrahi M., Lalazar G., Ben Ya.acov A. et al. Beta-glycoglycosphingolipidinduced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination // Vaccine. 2008. V. 26 (21). P. 2589 . 2595.
  36. Ni Y.H., Ho M.C., Wu J.F. "ut al. Response to booster hepatitis B vaccines in liver-transplanted children primarily vaccinated in infancy // Transplantation. 2008. V. 86 (11). P. 1531 . 1535.
  37. Nystrom J., Cardell K., Bjornsdottir T.B. et al. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine // Vaccine. 2008. V. 26 (47). P. 5967 . 5972.
  38. Pasricha N., Datta U., Chawla Y. et al. Poor responses to recombinant HBV vaccination in patients with HIV infection // Trop. Gastroenterol. 2005. V. 26 (4). P. 178 . 182.
  39. Perrie Y., Mohammed A.R., Kirby D.J. et al. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens // Int. J. Pharm. 2008. V. 364 (2). P. 272 . 280.
  40. Roome A.J., Walsh S.J., Cartter M.L., Hadler J.M. Hepatitis "B vaccine responsiveness in Connecticut public safety personnel // JAMA. 1993. V. 270. P. 2931 . 2934.
  41. Rosi. I., Mali.evi. S., Medi. S. The significance of age and sex for the absence of immune response to hepatitis B vaccination // Srp. Arh. Celok. Lek. 2008. V. 136 (1 . 2). P. 33 . 37.
  42. Rushbrook S.M., Hoare M., Alexander G.J. T-regulatory lymphocytes and chronic viral hepatitis // Expert. Opin. Biol. Ther. 2007. V. 7 (11). P. 1689 . 1703.
  43. Tuaillon E., Tabaa Y.A., Petitjean G. et al. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay // J. Immunol. Methods. 2006. V. 315 (1 . 2). P. 144 . 152.
  44. Van den Berg R., van Hoogstraten I., van Agtmael M. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions // AIDS Rev. 2009. V. 11 (3). P. 157 . 164.
  45. Van der Sande M.A., Waight P.A., Mendy M. et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence // PLoS ONE 2007. V. 2. e753.
  46. Vandepapeliere P., Horsmans Y., Moris P. et al. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers // Vaccine. 2008. V. 26 (10). P. 1375 . 1386.
  47. Velu V., Saravanan S., Nandakumar S. et al. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines // World J. Gastroenterol. 2008. V. 14 (22). P. 3534 – 3540.
  48. Wang R.X., Boland G.J., van Hattum J., de Gast G.C. Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination // World J. Gastroenterol. 2004. V. 10 (2). P. 260 – 263.
  49. Weihrauch M.R., von Bergwelt-Baildon M., Kandic M. et al. T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals // World J. Gastroenterol. 2008. V. 14 (16). P. 2529 – 2533.
  50. Xie Y., Sun H.X., Li D. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen // Vaccine. 2009. V. 27 (5). P. 757 – 764.
  51. Zhu X.L., Du T., Li J.H. еt al. Association of HLA-DQB1 gene polymorphisms with outcomes of HBV infection in Chinese Han population // Swiss Med. Wkly. 2007. V. 137 (7 – 8). P. 114 – 120.